Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm's Canal Microstent in Combination Cataract and Glaucoma Surgery.

MLA

Ahmed, Iqbal Ike K., et al. “Long-Term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery.” Ophthalmology, vol. 129, no. 7, July 2022, pp. 742–51. EBSCOhost, https://doi.org/10.1016/j.ophtha.2022.02.021.

APA

Ahmed, I. I. K., De Francesco, T., Rhee, D., McCabe, C., Flowers, B., Gazzard, G., Samuelson, T. W., & Singh, K. (2022). Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery. Ophthalmology, 129(7), 742–751. https://doi.org/10.1016/j.ophtha.2022.02.021

Chicago

Ahmed, Iqbal Ike K, Ticiana De Francesco, Douglas Rhee, Cathleen McCabe, Brian Flowers, Gus Gazzard, Thomas W Samuelson, and Kuldev Singh. 2022. “Long-Term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery.” Ophthalmology 129 (7): 742–51. doi:10.1016/j.ophtha.2022.02.021.